<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR16">
 <label>16.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Bosch</surname>
    <given-names>BJ</given-names>
   </name>
   <name>
    <surname>Martina</surname>
    <given-names>BE</given-names>
   </name>
   <name>
    <surname>Van Der Zee</surname>
    <given-names>R</given-names>
   </name>
   <name>
    <surname>Lepault</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Haijema</surname>
    <given-names>BJ</given-names>
   </name>
   <name>
    <surname>Versluis</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Heck</surname>
    <given-names>AJ</given-names>
   </name>
   <name>
    <surname>De Groot</surname>
    <given-names>R</given-names>
   </name>
   <name>
    <surname>Osterhaus</surname>
    <given-names>AD</given-names>
   </name>
   <name>
    <surname>Rottier</surname>
    <given-names>PJ</given-names>
   </name>
  </person-group>
  <article-title>Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides</article-title>
  <source>Proc Natl Acad Sci USA.</source>
  <year>2004</year>
  <pub-id pub-id-type="doi">10.1073/pnas.0400576101</pub-id>
  <?supplied-pmid 15150417?>
  <pub-id pub-id-type="pmid">15150417</pub-id>
 </element-citation>
</ref>
